A call to action: Issuing a diversity and inclusion challenge to research organizations
- PMID: 34191409
- PMCID: PMC8604251
- DOI: 10.1111/cts.13105
A call to action: Issuing a diversity and inclusion challenge to research organizations
Abstract
Individuals who identify as Black, indigenous, and people of color face well-documented health disparities. A root cause is the lack of empiric evidence for or against the use of various treatments in their medical management. This communication proposes a new benchmarking strategy for evaluating racial and ethnic representation in clinical research that can be compared across institutions with the intent of increasing accountability for diversity and inclusion among organizations that conduct clinical research.
© 2021 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics.
Conflict of interest statement
The authors declared no competing interests for this work.
Figures


References
-
- National Institutes of Health Revitalization Act, Pub L No. 103–43, 107 Stat 102 (1993). https://www.gpo.gov/fdsys/pkg/STATUTE‐107/pdf/STATUTE‐107‐Pg122.pdf.
-
- Best Pharmaceuticals for Children Act (2002), United States Public Law No. 107–109.
-
- Simpson EH. Measurement of diversity. Nature. 1949;163:688.
-
- NIH Research Portfolio Online Reporting Tools (RePORT) . Inclusion of women and minorities in clinical research. https://report.nih.gov/research/inclusion‐women‐and‐minorities‐clinical‐...
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous